The inferior colliculus (IC) is critical in initiating acoustically evoked alcohol withdrawal-induced seizures (AWSs). Recently, we reported that systemic inhibition of Ca 2+ entry via the reverse mode activity of the Na + /Ca 2+ exchanger (NCX rev ) suppressed AWSs, suggesting remodeling of NCX expression and function, at least in the IC the site of AWS initiation. Here, we probe putative changes in protein expression in the IC of NCX isoforms, including NCX type 1 (NCX1), 2 (NCX2), and 3 (NCX3). We also evaluated the e cacy of targeted inhibition of NCX1 rev and NCX3 rev activity in the IC on the occurrence and severity of AWSs using SN-6 and KB-R943, respectively. We used our well-characterized alcohol intoxication/withdrawal model associated with enhanced AWS susceptibility. IC tissues from the alcohol-treated were collected 3 hours (before the onset of AWS susceptibility), 24 hours (when AWS susceptibility is maximal), and 48 hours (when AWS susceptibility is resolved) following alcohol withdrawal; in comparison, IC tissues from the control-treated group were collected at 24 hours after the last gavage. Analysis shows that NCX1 protein levels were markedly higher 3 and 24 hours following alcohol withdrawal. However, NCX3 protein levels were only higher 3 hours following alcohol withdrawal. The analysis also reveals that intra-IC microinjection of SN-6 (but not KB-R7943) markedly suppressed the occurrence and severity of AWSs.Together, these ndings indicate that NCX1 is a novel molecular target that may play an essential role in the pathogenesis and pathophysiology of AWSs.